SBLOF (Shin Nippon Biomedical Laboratories) Total Assets: $662.0 Mil (As of Mar. 2026)


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
77 GF Score
Price $9.16
GF Value $14.46
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Total Assets?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 77 Total Assets is $662.0 Mil as of Mar. 2026. GuruFocus rates SBLOF with a GF Score™ of 77/100 and a GF Value™ of $14.46. The stock has 5 warning signs investors should review.

Shin Nippon Biomedical Laboratories's Total Assets for the quarter that ended in Mar. 2026 was $662.0 Mil.

Warning Sign:

If a company builds assets at 27.2% a year, faster than its revenue growth rate of 17.7% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Shin Nippon Biomedical Laboratories's average Total Assets Growth Rate was 7.60% per year. During the past 3 years, the average Total Assets Growth Rate was 22.80% per year. During the past 5 years, the average Total Assets Growth Rate was 27.20% per year. During the past 10 years, the average Total Assets Growth Rate was 5.60% per year.

During the past 13 years, Shin Nippon Biomedical Laboratories's highest 3-Year average Total Assets Growth Rate was 35.50%. The lowest was -17.10%. And the median was 7.00%.

Total Assets is connected with ROA %. Shin Nippon Biomedical Laboratories's annualized ROA % for the quarter that ended in Mar. 2026 was 8.34%. Total Assets is also linked to Revenue through Asset Turnover. Shin Nippon Biomedical Laboratories's Asset Turnover for the quarter that ended in Mar. 2026 was 0.10.

Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) Total Assets Explanation

Total Assets is connected with ROA %.

Shin Nippon Biomedical Laboratories's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=57.872/( (725.271+662.048)/ 2 )
=57.872/693.6595
=8.34 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shin Nippon Biomedical Laboratories's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=71.395/( (725.271+662.048)/ 2 )
=71.395/693.6595
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shin Nippon Biomedical Laboratories Total Assets Related Terms

Shin Nippon Biomedical Laboratories Total Assets Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories Total Assets Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 331.54 428.25 509.30 620.01 662.05

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 620.01 616.48 615.29 725.27 662.05
SBLOF
77GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shin Nippon Biomedical Laboratories's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=274.064+387.983
=662.0

Shin Nippon Biomedical Laboratories's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=274.064+387.983
=662.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $662.0 Mil mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a Total Assets of $662.0 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Shin Nippon Biomedical Laboratories and its competitors.
Is Shin Nippon Biomedical Laboratories' Total Assets too high?
Shin Nippon Biomedical Laboratories' current Total Assets is $662.0 Mil. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Total Assets compare to TMO and DHR?
Shin Nippon Biomedical Laboratories' Total Assets of $662.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Diagnostics & Research company?
A good Total Assets depends on the Medical Diagnostics & Research industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current Total Assets is $662.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current Total Assets of $662.0 Mil. The stock's GF Value™ is $14.46, compared to a current price of $9.16 — trading 36.6% below its estimated fair value. The current Total Assets is $662.0 Mil. Shin Nippon Biomedical Laboratories' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current Total Assets is $662.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 36.6% below its estimated GF Value™ of $14.46.

Key valuation signals for SBLOF:

  • Total Assets: $662.0 Mil
  • GF Value™: $14.46 vs. price of $9.16 (36.6% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
77GF Score

Get the complete analysis for SBLOF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$14.46
GF Value